Cargando…
Experimental Intrastriatal Applications of Botulinum Neurotoxin-A: A Review
Parkinson’s disease (PD) is one of the most frequent neurodegenerative disorders. Its main pathophysiological characteristic is the loss of dopaminergic neurons in the substantia nigra pars compacta followed by a lack of striatal dopaminergic input and a consequent disinhibition of tonically active...
Autores principales: | Hawlitschka, Alexander, Wree, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983629/ https://www.ncbi.nlm.nih.gov/pubmed/29735936 http://dx.doi.org/10.3390/ijms19051392 |
Ejemplares similares
-
Repeated Intrastriatal Botulinum Neurotoxin-A Injection in Hemiparkinsonian Rats Increased the Beneficial Effect on Rotational Behavior
por: Hawlitschka, Alexander, et al.
Publicado: (2018) -
Botulinum Neurotoxin-A Injected Intrastriatally into Hemiparkinsonian Rats Improves the Initiation Time for Left and Right Forelimbs in Both Forehand and Backhand Directions
por: Antipova, Veronica, et al.
Publicado: (2019) -
Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease
por: Antipova, Veronica, et al.
Publicado: (2021) -
[(18)F]fallypride-PET/CT Analysis of the Dopamine D(2)/D(3) Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection
por: Mann, Teresa, et al.
Publicado: (2018) -
Olfactory Bulb D(2)/D(3) Receptor Availability after Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease
por: Alberts, Teresa, et al.
Publicado: (2022)